Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 16Phase 3 7Phase 4 5Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Breast 2Other hematologic neoplasm 1

Conditions

Breast Neoplasms 630Triple Negative Breast Neoplasms 166Ovarian Neoplasms 103Carcinoma, Non-Small-Cell Lung 100Neoplasm Metastasis 76Colorectal Neoplasms 64Melanoma 61Stomach Neoplasms 60Neoplasms 56Pancreatic Neoplasms 55Squamous Cell Carcinoma of Head and Neck 50Prostatic Neoplasms 48Endometrial Neoplasms 48Lung Neoplasms 47Uterine Cervical Neoplasms 36Carcinoma, Renal Cell 35Sarcoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Breast Neoplasms, Male 29Urinary Bladder Neoplasms 26Small Cell Lung Carcinoma 26Colonic Neoplasms 26Carcinoma, Transitional Cell 23Carcinoma, Ovarian Epithelial 21Lymphoma 18Brain Neoplasms 18Kidney Neoplasms 17Carcinoma, Hepatocellular 17Liver Neoplasms 15

Interventions

Perindopril 1Bisoprolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Cardiotoxicity × Breast × Clear all
NCT04737265 2025-07-03

NTproBNP-Guide

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
101 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiomyopathies, Cardiotoxicity

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown
99 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡